Mckesson Medical-Surgical Inc. Corporate Office 2025-06-04 Health serious FDA
Health · FDA · Recall #FDA-Z-1854-2025
SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET. Recall
Issued June 4, 2025 · Mckesson Medical-Surgical Inc. Corporate Office
In June 2025, Mckesson Medical-Surgical Inc. Corporate Office recalled the SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET., a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
What you should do
- 1 Stop using SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET. right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Mckesson Medical-Surgical Inc. Corporate Office to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Health
- Recall date
- June 4, 2025
- Units affected
- Not reported
- Sold at
- US Nationwide distribution in the states of AL, AR, IL, KS, MT, NC, NJ, OR, SC, TN & WV.
- Recall number
- FDA-Z-1854-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Mckesson Medical-Surgical Inc. Corporate Office has 76 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.